|
author archive
This Week's Biotech Highlights
by Jeremy
Grushcow
October 4th, 2010
This week in biotech was pretty mellow, fellow denizens (and residents) of Slaw.
Health Canada is taking a “relaxed approach" to direct-to-consumer genetics tests, saying that personal test kits are… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
September 27th, 2010
With Fall in the air, this week in biotech was full of change, as Canadian biotech advocates converged on Ottawa and new priorities were the order of the day:
A report… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
September 20th, 2010
For those who think "tiff" is a file format for quantitative gel scans, I hardly need to point out that we are in the midst of National Biotechnology Week here in Canada… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
August 9th, 2010
Actually, it's this fortnight's biotech highlights as we catch up from the long weekend. Like everything else in this feels like 35° summer, the biotech market freeze is melting a bit.… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
July 26th, 2010
This week, as Quebec moved towards paying for in vitro fertilization with the goal of reducing expensive and risky multiple births (which may or may not work), it was hard to… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
July 19th, 2010
This week in biotech was the same all over the world. E&Y brought their "Beyond Borders" roadshow to Toronto and walked a crowd at MaRS through a retrospective of 2009's biotech… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
June 28th, 2010
Canadian biotech funding came from diverse sources this week.
Even deals that looked traditional, such as Aquinox's $25 million raise, included corporate venture capital funds (in this case J&J and Pfizer). These pharma-backed venture… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
June 21st, 2010
This week in biotech, regulators ran amok.
On the plus side, the FDA approved two new drugs this past week, including one — prostate cancer drug Jevtana — months ahead… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
June 14th, 2010
This week in biotech, indirect effects were predominant.
The generally poor performance of most recent biotech IPOs has indirectly boosted M&A activity. Only 1 of 8 U.S. biotech IPOs in… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
June 7th, 2010
It was a slimming week in the world of biotech.
Orexigen's obesity drug, Contrave, was accepted for FDA review. Contrave joins weight-loss medicines from Arena and Vivus in the FDA hopper.… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
May 31st, 2010
This week, a deal far away from home helped bring closer to home one of the challenges facing the biotech industry. Abbott labs bought a unit of India's Piramal healthcare,… [more]
This Week's Biotech Highlights
by Jeremy
Grushcow
May 17th, 2010
This week in biotech, everyone was taking up a challenge.
Grand Challenges Canada was launched this week to spend $225 million of the Canadian government's money on 5 "grand challenges" over… [more]
|
the count:
8642 posts | 11937 comments
recent comments 
This is the second in a series of ten tips dealing with cash flow reports and cash flow management. Gregory Nunn once said: “Never underestimate the value of cold cash.”… »»Practice Today’s Tip: Monitor UN documents with RSS Since I last looked, the United Nations Documents site has a new look and feel. For what the site is trying to deliver, … »»Research Last spring, Meritas’ Leadership Institute released a Social Media Guide for Lawyers. This helpful resource provided lawyers with an overview of the three main social media tools — LinkedIn, Faceb. […] »»Technology
-
-
-
Available online today are four new chapters of the publication Women in Canada: A Gender-based Statistical Report, which explores the socio-demographic and economic circumstances of Canadian women in general.
-
The bill amends the Constitution Act, 1867 by readjusting the number of members and the representation of the provinces in the House of Commons.
-
-
Blueseed plans to buy a ship and turn it into a floating incubator anchored in international waters off the coast of California.
-
Under Prime Minister Stephen Harper, the flow of information out of Ottawa has slowed to a trickle.
-
-
"…the IPC has exclusive jurisdiction to decide whether a record is in the custody or control of a university in the context of an access request…"
-
These summaries of selected recent cases are provided each week to Slaw by Maritime Law Book. More information.
-
Aliens - Exclusion and expulsion - Power to detain and deport - Minister’s certificate - Review - Evidence
In 2002, Harkat was detained pursuant to a ministerial security certificate issued under the Immigration and Refugee Protection Act (IRPA) as a person inadmissible to Canada on grounds ...
-
Contracts - Formation of contract - Signing - Electronic signature
The plaintiff expressed an interest in purchasing the defendant’s (vendor’s) condo. The parties agreed to carry on their discussions through e-mail. Following an exchange of e-mails, the plaintiff claimed that the defendant was contractually bound to ...
-
Barristers and Solicitors - Relationship with client - Confidential communications - General
The petitioner was a Receiver appointed in March 2009 by a California court over the assets of GJB Enterprises Inc. (a “Ponzi scheme”) and its principals, the Berkes (the GJB parties). The court ordered ...
-
Practice - Costs - Funding before judgment - When interim or advance costs available
The plaintiffs were “direct to home” satellite based subscription program providers. Rex and other defendants offered “grey market” services to Canadian residents to facilitate the unauthorized reception in Canada of the plaintiffs’ ...
This is a listing of a few upcoming events in Canada of interest to lawyers, law students, legal librarians, and others involved in the practice of law.
Clicking on any event in the list below will give you access to more information and to links allowing you to see the full entry and to add the event to your own calendar.
Click this link for a fuller version of the TalkLaw/ParLoi calendar of events and for instructions as to how to add events and calendars to your own calendar.
|